Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors
Clinical trial NCT06169124 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06169124
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-08
- Primary completion
- 2026-02-10
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.